Marshall Wace’s BioTelemetry, Inc. BEAT Stock Holding History

Marshall Wace’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-22,339	Closed	-$1.01M	–	2110
2020 Q2	$1.01M	Buy	+22,339	New	+$1M	0.01%	990
2019 Q4	–	Sell	-1,600	Closed	-$65K	–	2303
2019 Q3	$65K	Sell	1,600 -67,581	-98%	-$2.92M	﹤0.01%	1446
2019 Q2	$3.33M	Buy	+69,181	New	+$3.64M	0.03%	615
2019 Q1	–	Sell	-362	Closed	-$22K	–	2277
2018 Q4	$22K	Buy	+362	New	+$21.7K	﹤0.01%	1521
2014 Q3	–	Sell	-28,453	Closed	-$204K	–	1204
2014 Q2	$204K	Buy	+28,453	New	+$226K	﹤0.01%	848

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Marshall Wace's BEAT Position: Q3 2020 in Review

Marshall Wace sold out of BioTelemetry, Inc. (BEAT) in Q3 2020, closing a stake of 22,339 shares — an estimated $1.01M sold.

Marshall Wace first reported a position in BEAT in Q2 2014 and held it in 5 quarters. The position peaked at $3.33M in Q2 2019. 209 funds tracked by Wall St. Rank hold BEAT as of Q3 2020.

Marshall Wace reported no remaining BioTelemetry, Inc. position as of Q3 2020 after selling out during the quarter.
Marshall Wace sold 22,339 BioTelemetry, Inc. shares in Q3 2020, an estimated $1.01M.
Marshall Wace first reported a position in BioTelemetry, Inc. in Q2 2014 and held it in 5 quarters.
Marshall Wace's BioTelemetry, Inc. position peaked at $3.33M in Q2 2019.
209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2020.

Based on Marshall Wace's 13F filing for Q3 2020, filed 16 Nov 2020.